SCOPUS 정보 검색 플랫폼

Journal of Computer-Aided Molecular Design

Volumn 25, Issue 7, 2011, Pages 607-610

Fragment-based lead discovery: Challenges and opportunities

(3) Sun, Chaohong a Petros, Andrew M a Hajduk, Philip J a

a ABBOTT LABORATORIES (United States)

Author keywords

Biologics; Fragment based drug design; Off shoring; Outsourcing

Indexed keywords

BIOLOGIC; DRUG DESIGN; FRAGMENT-BASED DRUG DESIGN; OFF-SHORING; PHARMACEUTICAL INDUSTRY;

OUTSOURCING;

ARTICLE; CAPILLARY ELECTROPHORESIS; DRUG DESIGN; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SCREENING; FINANCIAL MANAGEMENT; FLUORESCENCE CORRELATION SPECTROSCOPY; FRAGMENT BASED DRUG DESIGN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; X RAY CRYSTALLOGRAPHY;

EID: 80051798254 PISSN: 0920654X EISSN: 15734951 Source Type: Journal
DOI: 10.1007/s10822-011-9451-z Document Type: Article

Times cited : (22)

References (25)

1
- 0029836953
- Discovering high-affinity ligands for proteins: SAR by NMR
- DOI 10.1126/science.274.5292.1531
- SB Shuker PJ Hajduk RP Meadows SW Fesik 1996 Science 274 1531 1534 10.1126/science.274.5292.1531 1:CAS:528:DyaK28Xnt1ansLs%3D (Pubitemid 26403929)
- (1996) Science , vol.274 , Issue.5292 , pp. 1531-1534
- Shuker, S.B.¹ Hajduk, P.J.² Meadows, R.P.³ Fesik, S.W.⁴

2
- 67649494337
- 10.1016/j.drudis.2009.03.009
- GE de Kloe D Bailey R Leurs IJ de Esch 2009 Drug Discov Today 14 630 646 10.1016/j.drudis.2009.03.009
- (2009) Drug Discov Today , vol.14 , pp. 630-646
- De Kloe, G.E.¹ Bailey, D.² Leurs, R.³ De Esch, I.J.⁴

3
- 46849089254
- Recent developments in fragment-based drug discovery
- DOI 10.1021/jm8000373
- M Congreve G Chessari D Tisi AJ Woodhead 2008 J Med Chem 51 3661 3680 10.1021/jm8000373 1:CAS:528:DC%2BD1cXotFKisLg%3D (Pubitemid 351956496)
- (2008) Journal of Medicinal Chemistry , vol.51 , Issue.13 , pp. 3661-3680
- Congreve, M.¹ Chessari, G.² Tisi, D.³ Woodhead, A.J.⁴

4
- 36549033318
- Integration of fragment screening and library design
- DOI 10.1016/j.drudis.2007.08.005, PII S1359644607003108
- G Siegal E Ab J Schultz 2007 Drug Discov Today 12 1032 1039 10.1016/j.drudis.2007.08.005 1:CAS:528:DC%2BD2sXhsVSmurnI (Pubitemid 350180558)
- (2007) Drug Discovery Today , vol.12 , Issue.23-24 , pp. 1032-1039
- Siegal, G.¹ Ab, E.² Schultz, J.³

5
- 36248944181
- An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes
- DOI 10.2174/156802607782341091
- JS Albert N Blomberg AL Breeze AJ Brown JN Burrows PD Edwards RH Folmer S Geschwindner EJ Griffen PW Kenny T Nowak LL Olsson H Sanganee AB Shapiro 2007 Curr Top Med Chem 7 1600 1629 10.2174/156802607782341091 1:CAS:528: DC%2BD2sXhsVOrur%2FM (Pubitemid 350131017)
- (2007) Current Topics in Medicinal Chemistry , vol.7 , Issue.16 , pp. 1600-1629
- Albert, J.S.¹ Blomberg, N.² Breeze, A.L.³ Brown, A.J.H.⁴ Burrows, J.N.⁵ Edwards, P.D.⁶ Folmer, R.H.A.⁷ Geschwindner, S.⁸ Griffen, E.J.⁹ Kenny, P.W.¹⁰ Nowak, T.¹¹ Olsson, L.-L.¹² Sanganee, H.¹³ Shapiro, A.B.¹⁴

6
- 33751204422
- Fragment-based lead discovery: A chemical update
- DOI 10.1016/j.copbio.2006.10.007, PII S0958166906001510
- DA Erlanson 2006 Curr Opin Biotechnol 17 643 652 10.1016/j.copbio.2006. 10.007 1:CAS:528:DC%2BD28Xht1eqs7zF (Pubitemid 44791912)
- (2006) Current Opinion in Biotechnology , vol.17 , Issue.6 , pp. 643-652
- Erlanson, D.A.¹

7
- 33751112979
- Puzzling through fragment-based drug design
- DOI 10.1038/nchembio1206-658, PII NCHEMBIO1206658
- PJ Hajduk 2006 Nat Chem Biol 2 658 659 10.1038/nchembio1206-658 1:CAS:528:DC%2BD28Xht1SrtLbI (Pubitemid 44764204)
- (2006) Nature Chemical Biology , vol.2 , Issue.12 , pp. 658-659
- Hajduk, P.J.¹

8
- 33845364148
- Fragment-based drug design: How big is too big?
- DOI 10.1021/jm060511h
- PJ Hajduk 2006 J Med Chem 49 6972 6976 10.1021/jm060511h 1:CAS:528:DC%2BD28XhtFOmtLbJ (Pubitemid 44885985)
- (2006) Journal of Medicinal Chemistry , vol.49 , Issue.24 , pp. 6972-6976
- Hajduk, P.J.¹

9
- 4344592378
- 10.1038/nrd1467 1:CAS:528:DC%2BD2cXmtVOht7Y%3D
- DC Rees M Congreve CW Murray R Carr 2004 Nat Rev Drug Discov 3 660 672 10.1038/nrd1467 1:CAS:528:DC%2BD2cXmtVOht7Y%3D
- (2004) Nat Rev Drug Discov , vol.3 , pp. 660-672
- Rees, D.C.¹ Congreve, M.² Murray, C.W.³ Carr, R.⁴

10
- 33847381100
- A decade of fragment-based drug design: Strategic advances and lessons learned
- DOI 10.1038/nrd2220, PII NRD2220
- PJ Hajduk J Greer 2007 Nat Rev Drug Discov 6 211 219 10.1038/nrd2220 1:CAS:528:DC%2BD2sXit12rtr4%3D (Pubitemid 46344625)
- (2007) Nature Reviews Drug Discovery , vol.6 , Issue.3 , pp. 211-219
- Hajduk, P.J.¹ Greer, J.²

11
- 67649341990
- 10.1016/j.drudis.2009.04.007 1:CAS:528:DC%2BD1MXotFyktLo%3D
- G Chessari AJ Woodhead 2009 Drug Discov Today 14 668 675 10.1016/j.drudis.2009.04.007 1:CAS:528:DC%2BD1MXotFyktLo%3D
- (2009) Drug Discov Today , vol.14 , pp. 668-675
- Chessari, G.¹ Woodhead, A.J.²

12
- 77649234756
- 1:CAS:528:DC%2BC3cXitFemsbg%3D
- SM Paul DS Mytelka CT Dunwiddie CC Persinger BH Munos SR Lindborg AL Schacht 2010 Nat Rev Drug Discov 9 203 214 1:CAS:528:DC%2BC3cXitFemsbg%3D
- (2010) Nat Rev Drug Discov , vol.9 , pp. 203-214
- Paul, S.M.¹ Mytelka, D.S.² Dunwiddie, C.T.³ Persinger, C.C.⁴ Munos, B.H.⁵ Lindborg, S.R.⁶ Schacht, A.L.⁷

13
- 0242291985
- Why is big Pharma getting out of antibacterial drug discovery?
- DOI 10.1016/j.mib.2003.08.003
- SJ Projan 2003 Curr Opin Microbiol 6 427 430 10.1016/j.mib.2003.08.003 (Pubitemid 37345405)
- (2003) Current Opinion in Microbiology , vol.6 , Issue.5 , pp. 427-430
- Projan, S.J.¹

14
- 23044491214
- Optimizing the discovery organization for innovation
- DOI 10.1016/S1359-6446(05)03539-7, PII S1359644605035397
- F Sams-Dodd 2005 Drug Discov Today 10 1049 1056 10.1016/S1359-6446(05) 03539-7 (Pubitemid 41074143)
- (2005) Drug Discovery Today , vol.10 , Issue.15 , pp. 1049-1056
- Sams-Dodd, F.¹

15
- 13844276627
- Target-based drug discovery: Is something wrong?
- DOI 10.1016/S1359-6446(04)03316-1, PII S1359644604033161
- F Sams-Dodd 2005 Drug Discov Today 10 139 147 10.1016/S1359-6446(04) 03316-1 1:CAS:528:DC%2BD2MXhsFarsbk%3D (Pubitemid 40247812)
- (2005) Drug Discovery Today , vol.10 , Issue.2 , pp. 139-147
- Sams-Dodd, F.¹

16
- 33646504430
- 10.1016/j.drudis.2006.04.014 1:CAS:528:DC%2BD28XkvVGjt7g%3D
- SE Hall 2006 Drug Discov Today 11 495 502 10.1016/j.drudis.2006.04.014 1:CAS:528:DC%2BD28XkvVGjt7g%3D
- (2006) Drug Discov Today , vol.11 , pp. 495-502
- Hall, S.E.¹

17
- 64049085062
- 10.1038/nrd2826 1:CAS:528:DC%2BD1MXjvV2ksLw%3D
- EE Schadt SH Friend DA Shaywitz 2009 Nat Rev Drug Discov 8 286 295 10.1038/nrd2826 1:CAS:528:DC%2BD1MXjvV2ksLw%3D
- (2009) Nat Rev Drug Discov , vol.8 , pp. 286-295
- Schadt, E.E.¹ Friend, S.H.² Shaywitz, D.A.³

18
- 31144438390
- 10.1038/nrd1904
- J van der Greef RN McBurney 2005 Nat Rev Drug Discov 4 961 967 10.1038/nrd1904
- (2005) Nat Rev Drug Discov , vol.4 , pp. 961-967
- Van Der Greef, J.¹ McBurney, R.N.²

19
- 77949370572
- 10.1111/j.1476-5381.2009.00476.x 1:CAS:528:DC%2BC3cXjs1ektro%3D
- M Congreve F Marshall 2010 Br J Pharmacol 159 986 996 10.1111/j.1476-5381.2009.00476.x 1:CAS:528:DC%2BC3cXjs1ektro%3D
- (2010) Br J Pharmacol , vol.159 , pp. 986-996
- Congreve, M.¹ Marshall, F.²

20
- 78149501220
- 10.1016/j.neuropharm.2010.07.016
- RE Hubbard 2010 Neuropharmacology 60 7 23 10.1016/j.neuropharm.2010.07. 016
- (2010) Neuropharmacology , vol.60 , pp. 7-23
- Hubbard, R.E.¹

21
- 79952382815
- 10.1016/B978-0-12-381274-2.00005-4 1:CAS:528:DC%2BC3MXosleku7c%3D
- M Congreve RL Rich DG Myszka F Figaroa G Siegal FH Marshall 2011 Methods Enzymol 493 115 136 10.1016/B978-0-12-381274-2.00005-4 1:CAS:528: DC%2BC3MXosleku7c%3D
- (2011) Methods Enzymol , vol.493 , pp. 115-136
- Congreve, M.¹ Rich, R.L.² Myszka, D.G.³ Figaroa, F.⁴ Siegal, G.⁵ Marshall, F.H.⁶

22
- 70449726880
- 10.1038/nrd3040 1:CAS:528:DC%2BD1MXhtlCjtr3F
- M Goodman 2009 Nat Rev Drug Discov 8 837 10.1038/nrd3040 1:CAS:528:DC%2BD1MXhtlCjtr3F
- (2009) Nat Rev Drug Discov , vol.8 , pp. 837
- Goodman, M.¹

23
- 34447336944
- 10.1002/biot.200790064 1:CAS:528:DC%2BD2sXnsVGjtrs%3D
- NS Wong HP Kocher MG Yap 2007 Biotechnol J 2 657 658 10.1002/biot. 200790064 1:CAS:528:DC%2BD2sXnsVGjtrs%3D
- (2007) Biotechnol J , vol.2 , pp. 657-658
- Wong, N.S.¹ Kocher, H.P.² Yap, M.G.³

24
- 34447297884
- Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies
- DOI 10.1111/j.1747-0285.2007.00535.x
- JR Huth C Park AM Petros AR Kunzer MD Wendt X Wang CL Lynch JC Mack KM Swift RA Judge J Chen PL Richardson S Jin SK Tahir ED Matayoshi SA Dorwin US Ladror JM Severin KA Walter DM Bartley SW Fesik SW Elmore PJ Hajduk 2007 Chem Biol Drug Des 70 1 12 10.1111/j.1747-0285.2007.00535.x 1:CAS:528: DC%2BD2sXovFCktrY%3D (Pubitemid 47057425)
- (2007) Chemical Biology and Drug Design , vol.70 , Issue.1 , pp. 1-12
- Huth, J.R.¹ Park, C.² Petros, A.M.³ Kunzer, A.R.⁴ Wendt, M.D.⁵ Wang, X.⁶ Lynch, C.L.⁷ Mack, J.C.⁸ Swift, K.M.⁹ Judge, R.A.¹⁰ Chen, J.¹¹ Richardson, P.L.¹² Jin, S.¹³ Tahir, S.K.¹⁴ Matayoshi, E.D.¹⁵ Dorwin, S.A.¹⁶ Ladror, U.S.¹⁷ Severin, J.M.¹⁸ Walter, K.A.¹⁹ Bartley, D.M.²⁰ more..

25
- 70350346470
- 10.1002/anie.200903821 1:CAS:528:DC%2BD1MXhtlWmur%2FK
- AW Hung HL Silvestre S Wen A Ciulli TL Blundell C Abell 2009 Angew Chem Int Ed Engl 48 8452 8456 10.1002/anie.200903821 1:CAS:528:DC%2BD1MXhtlWmur%2FK
- (2009) Angew Chem Int Ed Engl , vol.48 , pp. 8452-8456
- Hung, A.W.¹ Silvestre, H.L.² Wen, S.³ Ciulli, A.⁴ Blundell, T.L.⁵ Abell, C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.